SETH HENDRIX: Open Payments
NPI 1821499823 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,609 in 134 payments from 18 companies in 2025. Trend: 2023 $2,049 · 2024 $2,498 · 2025 $2,609
Food & beverage: $2,549Education: $60
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 40 | $675 |
| ABBVIE INC. | 29 | $587 |
| UCB, Inc. | 12 | $308 |
| Novartis Pharmaceuticals Corporation | 18 | $264 |
| Mallinckrodt Hospital Products Inc. | 8 | $234 |
| E.R. Squibb & Sons, L.L.C. | 7 | $132 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| Radius Health, Inc. | 2 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| Organon LLC | 3 | $46 |
Products named: RINVOQ, Otezla, Bimzelx, COSENTYX, ACTHAR, SKYRIZI, ORENCIA, TAVNEOS.
Industry payments across LA — which companies pay providers there.
